Menu
Currency
GWAS Study

Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia.

Trinder M, Vikulova D, Pimstone S et al.

34906840 PubMed ID
GWAS Study Type
349222 Participants
237 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

TM
Trinder M
VD
Vikulova D
PS
Pimstone S
MG
Mancini GBJ
BL
Brunham LR
Chapter II

Abstract

Summary of the research findings

Background and aims: Familial combined hyperlipidemia (FCHL) is one of the most common inherited lipid phenotypes, characterized by elevated plasma concentrations of apolipoprotein B-100 and triglycerides. The genetic inheritance of FCHL remains poorly understood. The goals of this study were to investigate the polygenetic architecture and cardiovascular risk associated with FCHL.

3,838 British ancestry cases, 345,384 British ancestry controls

Chapter III

Study Statistics

Key metrics and study information

349222
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.